Data updated: Mar 29, 2026
VASOSTRICT
VASOPRESSIN
Approved 2014-04-17
1
Indication
--
Phase 3 Trials
11
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2014-04-17
- Routes
- INTRAVENOUS
- Dosage Forms
- SOLUTION
VASOSTRICT Approval History
Loading approval history...
What VASOSTRICT Treats
1 FDA approvalsOriginally approved for its first indication in 2014 .
- Other (1)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
VASOSTRICT FDA Label Details
ProVASOSTRICT Patents & Exclusivity
Latest Patent: Jan 2035
Patents (282 active)
US9375478
Expires Jan 30, 2035
US9744209
Expires Jan 30, 2035
US9937223
Expires Jan 30, 2035
US9744239
Expires Jan 30, 2035
US10010575
Expires Jan 30, 2035
US9981006
Expires Jan 30, 2035
US9974827
Expires Jan 30, 2035
US9968649
Expires Jan 30, 2035
US9962422
Expires Jan 30, 2035
US9925234
Expires Jan 30, 2035
+ 272 more patents
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.